Renalytix plc (RNLX) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 1 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Apr 24, 2024 involved a transaction of 9,360,374 shares valued at $2.3M.
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 24, 2024 | Of Medicine At Mount Sinai Icahn School | Executive | Other | 9,360,374 | $0.25 | $2.3M | Large |
No significant insider buying has been recorded for RNLX in the recent period.
No significant insider selling has been recorded for RNLX in the recent period.
Based on recent SEC filings, insider sentiment for RNLX is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at Renalytix plc (RNLX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading RNLX stock, having executed 1 transactions in the past 90 days. The most active insider is School Of Medicine At Mount Sinai Icahn (Executive), who has made 1 transactions totaling $2.3M.
Get notified when executives and directors at RNLX file new Form 4 transactions
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 1 | $2.3M | 100.0% |
Insider activity at Renalytix plc shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.1 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, School Of Medicine At Mount Sinai Icahn, has transacted $2.3M during this period.